Skip to main content
Atrás
Watch Compare

Petros Pharmaceuticals, Inc.

Calidad de datos: 100%
PTPI
OTC Manufacturing Chemicals
$0.01
$0.00 (0.00%)
Cap. Mercado: 254,233.0
Precio
$0.01
Cap. Mercado
254,233.0
Rango del Día
$0.01 — $0.01
Rango de 52 Semanas
$0.00 — $2.63
Volumen
10,001
Apertura $0.01
Promedio 50D / 200D
$0.01
17.81% below
Promedio 50D / 200D
$0.02
67.03% below

Quick Summary

Puntos Clave

Negative free cash flow of -4.86 M
Capital efficient — spends only 3.39% of revenue on capex

Crecimiento

Revenue Growth (5Y)
N/A
Revenue (1Y)-12.20%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Calidad

Return on Equity
-179.74%
Below sector avg (-51.02%)
ROIC-270.52%
Net Margin-968.20%
Op. Margin-1844.57%

Seguridad

Debt / Equity
N/A
Current Ratio2.22
Interest Coverage-32.05

Valoración

PE (TTM)
-0.04
Above sector avg (-1.98)
P/B Ratio0.08
EV/EBITDAN/A
Dividend YieldN/A

Historial de Precios

Tendencias Financieras

Comparación con Pares

vs mediana del sector Manufacturing (44 pares)
Métrica Acción Mediana del Sector
P/E 0.0 -2.0
P/B 0.1 5.1
ROE % -179.7 -51.0
Net Margin % -968.2 -150.2
Rev Growth 5Y % — 9.3
D/E — 0.3

All Fundamental Metrics
Growth
Revenue Growth (1Y) -12.20% Revenue Growth (3Y) -7.63%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 725,403.0 Net Income (TTM) -7.02 M
ROE -179.74% ROA -103.82%
Gross Margin 63.50% Operating Margin -1844.57%
Net Margin -968.20% Free Cash Flow (TTM) -4.86 M
ROIC -270.52% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 2.22
Interest Coverage -32.05 Asset Turnover 0.11
Working Capital 3.37 M Tangible Book Value 3.37 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -0.04 Forward P/E N/A
P/B Ratio 0.08 P/S Ratio 0.35
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -1911.77%
Market Cap 254,233.0 Enterprise Value -5.82 M
Per Share
EPS (Diluted TTM) -3.11 Revenue / Share 0.02
FCF / Share -0.11 OCF / Share -0.11
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 3.39% FCF Conversion 69.20%
SBC-Adj. FCF N/A Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021
Revenue 5.11 M 5.82 M 5.99 M 7.81 M
Net Income -14.32 M -8.16 M -20.04 M -8.99 M
EPS (Diluted) -3.34 -6.35 -9.68 -0.83
Gross Profit 3.90 M 4.19 M 3.70 M 6.21 M
Operating Income -17.68 M -13.62 M -19.92 M -18.05 M
EBITDA — — — —
R&D Expenses 2.62 M 2.41 M 1.74 M 1.79 M
SG&A Expenses 8.75 M 9.26 M 12.21 M 15.59 M
D&A 2.83 M 3.28 M 5.60 M 6.88 M
Interest Expense 560,909.0 515,311.0 596,018.0 368,660.0
Income Tax 0.0 — — 0.0

Balance Sheet

Annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021
Total Assets 10.64 M 33.80 M 32.42 M 67.39 M
Total Liabilities 18.10 M 21.32 M 15.72 M 31.85 M
Shareholders' Equity -7.47 M 12.07 M 16.70 M 35.54 M
Total Debt — — — —
Cash & Equivalents 3.71 M 13.30 M 9.43 M 23.85 M
Current Assets 7.29 M 20.39 M 14.67 M 30.54 M
Current Liabilities 18.03 M 10.77 M 7.07 M 30.98 M